Numerous meta-analyses of randomized and prospective studies on the effects of flavonoids on liver enzymes in NAFLD patients suggested a relationship between the various flavonoid interventions and a significant reduction in the liver enzymes, such as ALT and AST levels [10,24,61,62,63,64,65]. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.